EYPT - EYEPOINT PHARMACEUTICALS INC
This page shows which of the focused investors we track hold EYPT and how their positions changed, so you can see how much conviction the group has in the stock.
In Q4 2018 it was held by 1 manager with an aggregate reported value of $54K, which is 0.00% of the combined portfolio.
As of Q4 2018, 1 tracked institutional manager held EYPT (EYEPOINT PHARMACEUTICALS INC) with an aggregate reported value of $54K — 0.00% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades EYPT — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q4 2018
- Ticker
- EYPT
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | David Katz - Matrix Asset Advisors | 0.01% | - | 28,500 | $54K |
Loading holder history for EYPT…